Gabapentin
Product Images NDC 16571-116

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 16571-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0b09cb8d B814 4c1d 9e2c 6673332bb807 01)

Chemical structure of gabapentin showing a cyclohexane ring with amino and carboxyl functional groups attached.*

FDA Label Image

Image (0b09cb8d B814 4c1d 9e2c 6673332bb807 02)

A line graph depicting mean pain scores over an 8-week period comparing placebo and gabapentin 3600 mg/day. The x-axis represents weeks spanning from baseline to week 8, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores on a numeric scale from 0 to 10. Gabapentin shows a declining pain score trend, while placebo remains relatively stable.*

FDA Label Image

Image (0b09cb8d B814 4c1d 9e2c 6673332bb807 03)

Line graph showing mean pain scores over a 7-week period comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline through 7 weeks, and the y-axis shows mean pain scores. The graph includes a 3-week dose titration period and a 4-week fixed dose period.*

FDA Label Image

Image (0b09cb8d B814 4c1d 9e2c 6673332bb807 04)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing results from two studies. Study 1 compares placebo (12%) with gabapentin 3600 mg (29%). Study 2 compares placebo (14%) with gabapentin 1800 mg (32%) and gabapentin 2400 mg (34%). Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Image (0b09cb8d B814 4c1d 9e2c 6673332bb807 05)

A scatter plot showing percentage difference versus daily dose (mg) for Gabapentin across three studies labeled a, b, and c. Different markers represent data points for each study at various doses ranging from 600 mg to 1800 mg, illustrating variability in response or effect size among the studies.*

FDA Label Image

Image (0b09cb8d B814 4c1d 9e2c 6673332bb807 06)

Label for Gabapentin Tablets USP, 600 mg strength, manufactured by Graviti Pharmaceuticals Pvt. Ltd. and distributed by Rising Pharma Holdings, Inc. The label indicates 100 tablets per package, storage instructions at 25°C with permitted excursions, and notes the product is for prescription use only (Rx only).*

FDA Label Image

Image (0b09cb8d B814 4c1d 9e2c 6673332bb807 07)

Gabapentin Tablets, USP 800 mg in a 100-tablet container. The label is from Rising Pharmaceuticals and designates the product as Rx only. It includes storage instructions, dispensing guidance, and manufacturer details for Graviti Pharmaceuticals Pvt. Ltd., with distribution by Rising Pharma Holdings, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.